POZ - News : Microbicide Proven Safe for Women
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » February 2008

Web Exclusives

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

Changing the HIV Treatment Paradigm

» More

Most Talked About

Magic Johnson Accused of Faking HIV (41)

The POZ/DDF Ratio (blog) (30)

Guidelines Prediction: Start Treatment Earlier (blog) (16)

HIV-Positive People Living Longer Than Ever Before (14)

Bone Marrow Transplant: Potential AIDS Cure? (8)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

February 25, 2008

Microbicide Proven Safe for Women

Scientists from the United States and India announced today that a vaginal microbicide gel currently in the trial stages is safe for daily use, Agence France-Presse reports (afp.google.com, 2/25). The findings were presented at the 2008 Microbicide Convention in New Delhi.

Researchers asked 200 HIV-negative sexually active women from New York and Pune, India, to use the experimental tenofovir gel for six months in addition to condoms. AFP reports that after that period, none of the women suffered disruption of kidney, blood or liver function, with more than 90 percent of women saying that they would use the gel if it were approved as being effective in preventing HIV transmission.

“Based on what we have learned we can proceed with greater confidence on a path that will answer whether tenofovir gel and other gels with HIV-specific compounds will be able to prevent sexual transmission of HIV in women when other approaches have failed to do so,” says lead researcher Sharon Hillier of the University of Pittsburg School of Medicine.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 3 (of 3 total)    

susie, council bluffs, 2008-02-27 09:40:17
I also want to know if it will prefent a women who is HIV+ from giving it to her partner if he doesnt have HIV.Once again for all of us who are positive,God Bless!!!!

Barb, San Luis Obispo, 2008-02-26 15:52:39
This is fine for women who are sexually active with a man who can achieve orgasm wearing a condom.

Susan, Boston, MA, 2008-02-26 09:11:02
What about a microbicide that HIV+ women can use to not infect their HIV- male partners? Does this work in that way, too?

comments 1 - 3 (of 3 total)    


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us when and to whom you disclose your status.

Tell us about your travel experiences.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy